Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

6.770
-0.170-2.45%
Volume:853.00K
Turnover:5.77M
Market Cap:5.52B
PE:-17.26
High:6.930
Open:6.940
Low:6.680
Close:6.940
52wk High:12.230
52wk Low:3.910
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:1.45
T/O Rate:0.10%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.392
ROE:-7.76%
ROA:-5.07%
PB:1.33
PE(LYR):-17.26
PS:8.93

Loading ...

Gf Securities: Domestic R&D Investment Demand Recovery Highlights Left-Side Opportunities in Pharma Sector

Stock News
·
Nov 20, 2025

Private equity firms among Ocumension Therapeutics' (HKG:1477) largest stockholders and were hit after last week's 5.8% price drop

Simply Wall St.
·
Nov 20, 2025

Eli Lilly's Donanemab Receives Approval in India for Alzheimer's Treatment

Deep News
·
Nov 19, 2025

Investor Claims Against Nanjing Aolian Ae&Ea (300585) and Hainan Poly Pharm (300630) Submitted for Filing

Deep News
·
Nov 18, 2025

Garden Group Drives High-Quality Development with Strong Momentum

Deep News
·
Nov 18, 2025

Pharmaceutical Sector Defies Market Downturn Amid 4,000-Point Tug-of-War: Fund Manager Insights

Deep News
·
Nov 16, 2025

SOUTH CHINA FIN (00619) Plans to Establish Joint Venture to Enter High-Growth Sectors Including AI Drug Development, Beauty Tech, and Anti-Aging Consumer Markets

Stock News
·
Nov 14, 2025

GF Securities: Pharmaceutical Sector Sees Profit Improvement in Q3 2025, Domestic Drugmakers Gain Global Competitiveness

Stock News
·
Nov 14, 2025

ASCLETIS-B (01672) Rises Over 4% Again as ASC36 and ASC35 Combo Advances to Clinical Development

Stock News
·
Nov 13, 2025

Pharmaceutical Sector Boosted as FDA Leadership Change Restores Market Confidence, Drug Stocks Hit Record Highs

Stock News
·
Nov 13, 2025

ASCLETIS-B (01672): Monthly-Dose Next-Gen Amylin Receptor Agonist ASC36 and GLP-1R/GIPR Dual-Target Agonist ASC35 Combo Advances to Clinical Development

Stock News
·
Nov 13, 2025

LAEKNA-B (02105) Enters Exclusive Licensing Agreement with Qilu Pharma for LAE 002 (Afuresertib) in China

Stock News
·
Nov 12, 2025

HK Stock Movement | ASCLETIS-B (01672) Surges Over 7% in Late Trading as ASC36 Enters Clinical Development Phase, IND Application to Be Submitted in Q2 Next Year

Stock News
·
Nov 11, 2025

Ionis Pharmaceuticals Pre-Market Shares Plunge Over 13%, Currently at $63.63

Deep News
·
Nov 10, 2025

Tiansheng Pharmaceutical Group Co.,Ltd. (002872) Penalized, Shareholder Compensation Claims Expected

Deep News
·
Nov 10, 2025

Weijian Pharma Submits Listing Application to HKEX, Leads in Commercialized Innovative Kidney Disease Drugs Among Chinese Pharma Firms

Stock News
·
Nov 10, 2025

Novartis AG (NVS.US) Gains Dual Indication Approval for First Radioligand Therapy Drug Pluvicto®

Stock News
·
Nov 06, 2025

MSCI Global Small Cap Index Rebalance: Ascletis-B (01672), Chabaidao (02555) Among 22 Stocks Added

Stock News
·
Nov 06, 2025

ASCLETIS-B (01672) Repurchased 100,000 Shares for HK$924,000 on November 5

Stock News
·
Nov 05, 2025

ASCLETIS-B (01672) Presents Full Analysis of ASC30 Oral Tablet Ib Study, ASC30 Injection Ib Study, and ASC31/ASC47 Combination Preclinical Research at ObesityWeek® 2025

Stock News
·
Nov 05, 2025